We will be closed during the holiday period from Friday 22nd December 2023 until Monday 15th January 2024. We will stop taking deliveries on Thursday 21st December 2023 and begin taking deliveries on Monday 8th January 2024.
.jpg)
This partnership is based on a shared commitment to high-quality, compliance-led manufacturing. Argus ManuTech, a leader in automotive, aerospace, rail, and defense manufacturing, is excited to expand its capabilities into the med-tech sector.
"We are thrilled to be partnering with MARS Bioimaging. Our imminent certification to ISO 13485:2016 and newly implemented digital transformation strategy ensure we are well prepared to work with another of New Zealand’s high-tech businesses. Our growth into the med-tech industry opens the doors to support the contract manufacturing requirements of both local and offshore medical device companies, supporting the advancement of the New Zealand manufacturing industry." said Nathan Hay, General Manager of Argus ManuTech.
Quality is paramount at Argus ManuTech, and their adherence to international standards such as ISO 9001 and ISO 14001 underscores this commitment. Working towards ISO 13485 certification, critical for medical device manufacturing, aligns perfectly with MARS Bioimaging’s mission to provide top-tier medical imaging solutions.
Mark Figgitt, CEO of MARS Bioimaging, emphasised the importance of quality in their products: "MARS needs to ensure we consistently produce high-quality and reliable scanners for deployment to our clinical customers. As a result, we engaged with Argus who are a proven manufacturer, working with a variety of NZ companies. The standards they work to are key for us to achieve repeatable quality levels for our product, which is critical when deploying medical devices globally."
To prepare for increasing demand on capacity, Argus ManuTech has recently undergone a digital transformation. This includes the development of a production automation strategy, establishing a centralised data platform with real-time production data, and completing a SIRI assessment. These advancements have driven efficiencies across their operations and fostered greater intercompany collaboration.
The partnership between these two proud Kiwi businesses will bring the next generation of medical imaging technology to the world. Both Argus ManuTech and MARS Bioimaging are excited about the future, as they continue to showcase the capability, growth, and advancement of New Zealand’s manufacturing sector.